Comparing the impact of nivolumab & ipilimumab combination therapy vs. dabrafenib & trametinib on outcomes in malignant melanoma patients: A global propensity-matched retrospective cohort study.
Authors: Abdul Wahab, Abdul Wali Khan, Muhammad Ishaq, Syeda Maryana Mufarrih, Abat Khan, Matthew Philip Salzberg, Atif Hussein